Abstract
GTPase Activating Protein (GAP) is involved in down–regulating normal ras proteins and in the signal transduction pathway of some growth factors. We have screened 188 human tumours for mutations in the catalytic domain and at the C terminal SH2 region GAP. Three nonsense mutations in basal cell carcinomas were detected in the SH2 region and no mutations could be demonstrated in the catalytic domain. We conclude that mutations in the SH2 region of GAP may play a role in tumorigenesis and that inactivating mutations of the GAP catalytic domain do not contribute to tumour development.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Barbacid, M. ras genes. A Rev. Biochem. 56, 779–827 (1987).
Patterson, H. et al. Activated N-ras controls the transformed phenotype of HT1080 human fibrosarcoma cells. Cell 51, 803–812 (1987).
Field, J., Broek, D., Kataoka, T. & Wigler, M. Guanine nucleotide activation of, and competition between, ras proteins from Saccharomyces Cerevisiae. Molec. cell. Biol. 7, 2128–2133 (1987).
Trahey, M. & McCormick, F. A cytoplasmic protein stimulates normal p21 ras GTPase, but does not affect oncogenic mutants. Science 238, 542–545 (1987).
Xu, G. et al. The neurofibromatosis type 1 gene encodes a protein related to GAP. Cell 62, 599–608 (1990).
Xu, G. et al. The catalytic domain of the neurofibromatosis type 1 gene product stimulates ras GTPase and complements IRA mutants of S.cerevisiae. Cell 63, 835–841 (1990).
Quaife, C.J., Pinkert, C.A., Ornitz, D.M., Palmiter, R.D. & Brinster, R.L. Pancreatic neoplasia induced by ras expression in acinar cells of transgenic mice. Cell 48, 1023–1034 (1987).
Trahey, M. et al. Biochemical and biological properties of the human N-ras p21 protein. Molec. cell. Biol. 7, 541–544 (1987).
Gibbs, B.G., Sigal, I.S., Poe, M. & Scolnick, E.M. Intrinsic GTPase activity distinguishes normal and oncogenic ras p21 molecules. Proc. natn. Acad. Sci. U.S.A. 81, 5704–5708 (1984).
Adari, H., Lowy, D.R., Willumsen, B.M., Der, C.J. & McCormick, F. Guanosine triphosphatase activating protein (GAP) interacts with the p21 ras effector binding domain. Science 240, 518–521 (1988).
Trahey, M. et al. Molecular cloning of two types of GAP complementary DNA from human placenta. Science 242, 1697–1700 (1988).
Marshall, M.S. et al. A C-terminal domain of GAP is sufficient to stimulate ras p21 GTPase activity. EMBO J. 8, 1105–1110 (1989).
Ballestar, R. et al. The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins. Cell 63, 851–859 (1990).
Tanaka, K. et al. S.cerevisiae genes IRA1 and IRA2 encode proteins that may be functionally equivalent to mammalian ras GTPase activating protein. Cell 60, 803–807 (1990).
Toda, T. et al. (1985) In yeast, ras proteins are controlling elements of adenylate cyclase. Cell 40, 27–36 (1985).
Ballester, R. et al. Genetic analysis of mammalian GAP expressed in yeast. Cell 59, 681–686 (1989).
Li, Y. et al. Somatic mutations in the neurofibromatosis 1 gene in human tumours. Cell 69, 275–281 (1992).
McCormick, F. The world according to GAP. Oncogene 5, 1281–1283 (1990).
Martin, G.A. et al. GAP domains responsible for Ras p21-dependent inhibition of muscarinic atrial K+channel currents. Science 255, 192–194 (1992).
Medema, R.H., de Laat, W.L., Martin, G.A., McCormick, F. & Bos, J.L. GTPase-activating protein SH2-SH3 domains induce gene expression in a ras-dependent fashion. Molec. cell. Biol. 12, 3425–3430 (1992).
Duchesne, M. et al. Identification of the SH3 domain of GAP as an essential sequence for ras-GAP-mediated signalling. Science 259, 525–528 (1993).
Ellis, C., Moran, M., McCormick, F. & Pawson, T. Phosphorylation of GAP and GAP-associated proteins by transforming and mitogenic tyrosine kinases. Nature 343, 377–381 (1990).
Anderson, D. et al. Binding of SH2 domains of PLC-γ1, GAP and src to activated growth factors. Science 250, 979–982 (1990).
Brott, B.K., Decker, S., Shafer, J., Gibbs, J.B. & Jove, R. GTPase activating protein interacting with viral and cellular src kinases. Proc. natn. Acad. Sci. U.S.A. 88, 755–759 (1991).
Klein, G. The approaching era of tumour suppressor genes. Science 238, 1539–1545 (1987).
Barbetti, F. et al. Detection of mutations in the insulin receptor gene by denaturing gradient gel electrophoresis. Diabetes 41, 408–415 (1992).
Myers, R.M., Fischer, S.G., Lerman, L.S. & Maniatis, T. Nearly all single base substitutions in DNA fragments joined by a GC-clamp can be detected by denaturing gradient gel electrophoresis. Nucl. Acids Res. 13, 3131–3145 (1985).
Miller, S.J. Biology of basal cell carcinoma. J. Amer. Acad. Dermatol. 24, 1–13 (1991).
Erlich, H.A., Gelfand, D. & Sninsky, J.J. Recent advances in the polymerase chain reaction. Science 252, 1643–1651 (1991).
Mertens, F. et al. Cytogenetic analysis of 33 basal cell carcinomas. Cancer Res. 51, 954–957 (1991).
Pierceall, W.E., Goldberg, L.H., Tainsky, M.A., Mukhopadhyay, T. & Ananthaswamy, H.N. Ras gene mutation and amplification in human nonmelanoma skin cancers. Molec. Carcinog. 4, 196–202 (1991).
Ananthaswamy, H.N., Applegate, L.A., Goldberg, L.H. & Bales, E.S. Detection of c-Ha-ras-1 allele in human skin cancers. Molec. Carcinog. 2, 298–301 (1989).
Nazami, M.N., Dykes, P.J. & Marks, P. Epidermal growth factor receptors in human epidermal tumours. Br. J. Dermatol. 123, 153–161 (1990).
Waxman, G., Shoelson, S.E., Pant, N., Cowburn, D. & Kuriyan, J. Binding of a high affinity phosphotyrosyl peptide to the src SH2 domain: crystal structures of the complexed and peptide free form. Cell 72, 779–790 (1993).
Booker, G.W. et al. Structure of an SH2 domain of the p85a subunit of phosphatdylinositol-3-OH Kinase. Nature 358, 684–687 (1992).
Koch, C.A., Anderson, D., Moran, M.F., Ellis, C. & Pawson, T. SH2 and SH3 domains: elements that control interactions of cytoplasmic signalling proteins. Science 252, 668–674 (1991).
Waksman, G. et al. Crystal structure of the phosphtyrosine recognition domain SH2 of v-src complexed with tyrosine phosphorylated peptides. Nature 358, 646–653 (1992).
Backer, J.M. et al. Phophatidylinositol 3′-kinase is activated by association with IRS-1 during insulin stimulation. EMBO J. 11, 3469–3479 (1992).
Mayer, B.J. & Baltimore, D. Signalling through SH2 and SH3 domains. Trends cell. Biol. 3, 8–13 (1993).
Fantl, W.J. et al. Distinct phosphotyrosines on a growth factor receptor bind to specific molecules that mediate different signalling pathways. Cell 69, 413–423 (1992).
Buday, L. & Downward, J. Epidermal growth factor regulates p21ras through the formation of a complex of receptor, GRB2 adaptor protein and SOS nucleotide exchange factor. Cell 73, 611–620 (1993).
Lowenstein, E.J. et al. The SH2 and SH3 domain containing protein GRB2 links receptor tyrosine kinases to ras signalling. Cell 70, 431–442 (1992).
Koch, C.A., Moran, M., Sadowski, I. & Pawson, T. The common src homology region 2 domain of cytoplasmic signalling proteins is a positive effector of V-fps tyrosine kinase function. Molec. cell. Biol. 9, 4131–4140 (1989).
Hirai, H. & Varmus, H.E. Site directed mutagenesis of the SH2 and SH3 domains of c-src produces varied phenotypes, including oncogenic activation of pp60c-src. Molec. cell. Biol. 10, 1307–1318 (1990).
Orita, M., Suzuki, Y., Sekiya, T. & Hayashi, K. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics 5, 874–879 (1989).
Gross-Bellard, J., Oudet, P. & Chambon, P. Isolation of high molecular weight DNA from mammalian cells. Eur. J. Biochem. 36, 32–38 (1973).
Jeanpierre, M. A rapid method for the purification of DNA from blood. Nucl. Acids Res. 15, 9611 (1987).
Greer, C.E., Peterson, S.L., Kiviat, N.B. & Manos, M.M. PCR amplification from paraffin embedded tissues. Am. J. clin. Path. 95, 117–124 (1991).
Lerman, L.S., Fischer, S.G., Hurley, I., Silverstein, K. & Lumelsky, N. Sequence determined DNA separations. Annu. Rev. Biophys. Bioeng. 13, 399–423 (1984).
Myers, R.M., Maniatis, T. & Lerman, L.S. Detection and localisation of single base changes by denaturing gradient gel electrophoresis. Meth. Enzymol. 155, 501–527 (1987).
Sheffield, V.C., Cox, D.R., Lerman, L.S. & Myers, R.M. Attachment of a 40-base pair G+C clamp to genomic DNA fragments by polymerase chain reaction results in improved detection of single base changes. Proc. natn. Acad. Sci. U.S.A. 86, 232–236 (1989).
Syvänen, A.C., Aalto-Setälä, K., Kontula, K. & Söderlund, H. Direct sequencing of affinity captured amplified human DNA: application to the detection of apolipoprotein E polymorphism. FEBS Lett. 258, 71–74 (1989).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Friedman, E., Gejman, P., Martin, G. et al. Nonsense mutations in the C–terminal SH2 region of the GTPase activating protein (GAP) gene in human tumours. Nat Genet 5, 242–247 (1993). https://doi.org/10.1038/ng1193-242
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ng1193-242
This article is cited by
-
Protein tyrosine phosphatase 1B targets PITX1/p120RasGAP thus showing therapeutic potential in colorectal carcinoma
Scientific Reports (2016)
-
Genome-wide genetic associations with IFNγ response to smallpox vaccine
Human Genetics (2012)
-
Detection of RASA1 mutations in patients with sporadic Sturge–Weber syndrome
Child's Nervous System (2011)
-
Ca2+ signalling checkpoints in cancer: remodelling Ca2+ for cancer cell proliferation and survival
Nature Reviews Cancer (2008)
-
A novel mutation in RASA1 causes capillary malformation and limb enlargement
Archives of Dermatological Research (2008)